The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
CREDIT DESIGNATION STATEMENT
AACR has designated this educational activity for a maximum of 27.75 AMA PRA Category 1 Credit(s)
™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE, AND LEARNING OBJECTIVES
Advances in technology, progress in prevention, and exponential developments in the field of translational cancer medicine have increased the importance of fostering dynamic collaborations among basic researchers, physicians, and clinician-scientists. Bridging the gap between what physicians understand about cancer biology and its application to clinical oncology is critical to the implementation of the most current, approved molecular-based tests to aid in the early detection and prevention of cancer. Moreover, facilitating the interface between physicians and scientists will increase physicians’ knowledge of the epidemiological implications of cancer incidence and the contributions of laboratory research to preventive drug development as well as patient care; transform the design and conduct of clinical research protocols; and, create a forum for the more rapid translation of laboratory research findings from “bench-to-bedside” for the benefit of improving patient outcomes.
After participating in this CME activity, physicians should be able to:
- Employ technological advances to accelerate progress in cancer research in order to improve early detection and early intervention prior to the development of invasive cancer, with the ultimate goal of extending patients’ lives
- Integrate molecular assays and new screening techniques with classic risk factors (such as family history, behaviors such as tobacco use, environmental exposures, and nutrition) to determine cancer susceptibility and predict lifetime risk
- Integrate the use of biomarkers of risk and biomarkers of response to intervention to more accurately develop prevention strategies
- Critically assess the results of clinical trials of preventive strategies to better explain the risk-benefit issues and challenges encountered in their use
It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the AACR will provide information that Scientific Program Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information is available below and will be available in the Program/Proceedings
of this conference.
ACKNOWLEDGMENT OF FINANCIAL OR OTHER SUPPORT
This activity is supported by grants and will be disclosed at the activity.
QUESTIONS ABOUT CME?
Please contact the Office of CME at (215) 440-9300 or firstname.lastname@example.org